Unknown

Dataset Information

0

Identification of potent tricyclic prodrug S1P1 receptor modulators.

ABSTRACT: Recently, our research group reported the identification of prodrug amino-alcohol 2 as a potent and efficacious S1P1 receptor modulator. This molecule is differentiated preclinically over the marketed drug fingolimod (Gilenya 1), whose active phosphate metabolite is an S1P1 full agonist, in terms of pulmonary and cardiovascular safety. S1P1 partial agonist 2, however, has a long half-life in rodents and was projected to have a long half-life in humans. The purpose of this communication is to disclose highly potent partial agonists of S1P1 with shorter half-lives relative to the clinical compound 2. PK/PD relationships as well as their preclinical pulmonary and cardiovascular safety assessment are discussed.

SUBMITTER: Marcoux D 

PROVIDER: S-EPMC6071880 | biostudies-other | 2017 Apr

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Recently, our research group reported the identification of prodrug amino-alcohol <b>2</b> as a potent and efficacious S1P<sub>1</sub> receptor modulator. This molecule is differentiated preclinically over the marketed drug fingolimod (Gilenya <b>1</b>), whose active phosphate metabolite is an S1P<sub>1</sub> full agonist, in terms of pulmonary and cardiovascular safety. S1P<sub>1</sub> partial agonist <b>2</b>, however, has a long half-life in rodents and was projected to have a long half-life  ...[more]

Similar Datasets

Unknown Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists.
| S-EPMC7110456 | biostudies-literature
Unknown Identification of potent ROR? modulators: Scaffold variation.
| S-EPMC6238650 | biostudies-literature
Unknown Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
| S-EPMC4027221 | biostudies-other
Unknown Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.
| S-EPMC3446783 | biostudies-literature
Unknown Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1).
| S-EPMC4018108 | biostudies-literature
Unknown Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS.
| S-EPMC4017978 | biostudies-literature
Unknown Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
| S-EPMC4867749 | biostudies-literature
Unknown Potent Prearranged Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor.
| S-EPMC5542757 | biostudies-literature
Unknown Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
| S-EPMC4789672 | biostudies-literature
Unknown Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-beta-lactamases.
| S-EPMC127244 | biostudies-literature